As a successful pharmaceutical company, we are investing in the future of medicine. We develop drugs of high medical value so as to continuously improve the quality of life. We make the most of knowledge. Using interdisciplinary networks we build bridges to academic researchers around the world, as well as to highly specialized biotech pioneers and partners in the pharmaceutical industry. We combine our own longstanding medical and pharmaceutical expertise with the latest discoveries from genomic research. Throughout, our research focuses on a meaningful combination of early diagnosis, prevention, treatment and therapy control. We focus on our chosen fields of expertise: Gynecology & Andrology, Oncology, Diagnostic Imaging, Specialized Therapeutics. As a global player with over 140 subsidiaries we are in close contact with our customers around the world.